These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4054217)

  • 1. In vivo stereospecific [3H]spiperone binding in rat brain: characteristics, regional distribution, kinetics and pharmacological properties.
    Barone D; Luzzani F; Assandri A; Galliani G; Mennini T; Garattini S
    Eur J Pharmacol; 1985 Oct; 116(1-2):63-74. PubMed ID: 4054217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
    Köhler C; Haglund L; Ogren SO; Angeby T
    J Neural Transm; 1981; 52(3):163-73. PubMed ID: 7198139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
    Köhler C; Ogren SO; Haglund L; Angeby T
    Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors.
    Palacios JM; Niehoff DL; Kuhar MJ
    Brain Res; 1981 Jun; 213(2):277-89. PubMed ID: 7248759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF; Van het Schip F; Sebens JB; Korf J
    Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical properties of spiperone binding to rat brain membranes.
    Sundermann RH; Wooten GF
    Pharmacology; 1980; 21(4):295-305. PubMed ID: 6106952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidol.
    Bischoff S
    Experientia; 1981; 37(9):1008-9. PubMed ID: 7297644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain.
    Pedigo NW; Yamamura HI; Nelson DL
    J Neurochem; 1981 Jan; 36(1):220-6. PubMed ID: 7463047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism by supidimide of haloperidol-induced augmentation of [3H]-spiperone binding in rat striatum.
    Hennies HH; Hess V; Flohé L
    Arzneimittelforschung; 1984; 34(11):1481-4. PubMed ID: 6543122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic proglumide increases [3H]spiperone binding in the rat brain.
    Bean AJ; Baldy WJ; Martin GE
    Eur J Pharmacol; 1985 Oct; 117(1):97-101. PubMed ID: 4085545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]spiperone binding in the nigrostriatal system in human brain.
    Ruberg M; Bokobza B; Javoy-Agid F; Montfort JC; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):159-65. PubMed ID: 6203765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific in vivo binding of 3H-spiperone to individual lobes of the pituitary gland of the rat. Evidence for the labelling of dopamine receptors.
    Köhler C; Fahlberg K
    J Neural Transm; 1985; 63(1):39-52. PubMed ID: 4031846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE
    J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo [3H]spiperone binding to the rat hippocampal formation: involvement of dopamine receptors.
    Bischoff S; Bittiger H; Krauss J
    Eur J Pharmacol; 1980 Dec; 68(3):305-15. PubMed ID: 7202494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.